UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses

Frontiers in immunology, 2020-05, Vol.11, p.940-940

2020

Volltextzugriff (PDF)

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Journal of neuroinflammation, 2012-05, Vol.9 (1), p.112-112, Article 576

2012

Volltextzugriff (PDF)

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

PloS one, 2013-01, Vol.8 (1), p.e55818-e55818

2013

Volltextzugriff (PDF)

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus

Clinical cancer research, 2017-10, Vol.23 (19), p.5846-5857

2017

Volltextzugriff (PDF)

Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

Cancer research (Chicago, Ill.), 2012-05, Vol.72 (9), p.2327-2338

2012

Volltextzugriff (PDF)

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

Human gene therapy, 2015-08, Vol.26 (8), p.498-505

2015

Volltextzugriff (PDF)

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

Viruses, 2015-11, Vol.7 (11), p.5780-5791

Loskog, Angelica

2015

Volltextzugriff (PDF)

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

Cancer Immunology and Immunotherapy, 2021-10, Vol.70 (10), p.2851-2865

2021

Volltextzugriff (PDF)

IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1

The Journal of immunology (1950), 2019-02, Vol.202 (3), p.787-798

2019

Volltextzugriff (PDF)

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40

Cancer gene therapy, 2020-12, Vol.27 (12), p.948-959

2020

Volltextzugriff (PDF)

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma

Investigational new drugs, 2020-10, Vol.38 (5), p.1448-1453

2020

Volltextzugriff (PDF)

The signaling and the metabolic differences of various CAR T cell designs

International immunopharmacology, 2023-01, Vol.114, p.109593-109593, Article 109593

2023

Volltextzugriff (PDF)

AdCD40L Immunogene Therapy for Bladder Carcinoma— The First Phase I/IIa Trial

Clinical cancer research, 2010-06, Vol.16 (12), p.3279-3287

2010

Volltextzugriff (PDF)

The Janus faces of CD40 in cancer

Seminars in immunology, 2009-10, Vol.21 (5), p.301-307

2009

Volltextzugriff (PDF)

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

Immunology, 2010-11, Vol.131 (3), p.371-376

2010

Volltextzugriff (PDF)

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Journal of neuroimmunology, 2014-12, Vol.277 (1), p.153-159

2014

Volltextzugriff (PDF)

Intranasal delivery of central nervous system‐retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis

Immunology, 2014-07, Vol.142 (3), p.431-441

2014

Volltextzugriff (PDF)

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

PloS one, 2015-12, Vol.10 (12), p.e0144787-e0144787

2015

Volltextzugriff (PDF)

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Frontiers in immunology, 2018-01, Vol.8, p.1956-1956

2018

Volltextzugriff (PDF)

Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

Molecular therapy. Oncolytics, 2021-03, Vol.20, p.508-518

2021

Volltextzugriff (PDF)

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

PloS one, 2022-09, Vol.17 (9), p.e0271293-e0271293

2022

Volltextzugriff (PDF)

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion

Cytotherapy (Oxford, England), 2017-06, Vol.19 (6), p.689-702

2017

Volltextzugriff (PDF)

T‐cell responses after haematopoietic stem cell transplantation for aggressive relapsing–remitting multiple sclerosis

Immunology, 2013-10, Vol.140 (2), p.211-219

2013

Volltextzugriff (PDF)

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Scientific reports, 2019-12, Vol.9 (1), p.18069-18069, Article 18069

2019

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(139)

Publikationsform

Artikel
(153)
Dissertationen
(1)

Sprache

Englisch
(154)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus

Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma

Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 study

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy

IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1

Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma

The signaling and the metabolic differences of various CAR T cell designs

AdCD40L Immunogene Therapy for Bladder Carcinoma— The First Phase I/IIa Trial

The Janus faces of CD40 in cancer

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention

Intranasal delivery of central nervous system‐retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis

Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients

Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

Donor-derived urologic cancers after renal transplantation: A retrospective non-randomized scientific analysis

Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion

T‐cell responses after haematopoietic stem cell transplantation for aggressive relapsing–remitting multiple sclerosis

Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients

Suchergebnisse filtern